348 related articles for article (PubMed ID: 26006300)
1. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
Asselta R; Robusto M; Platé M; Santoro C; Peyvandi F; Duga S
Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300
[TBL] [Abstract][Full Text] [Related]
2. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.
Asselta R; Platè M; Robusto M; Borhany M; Guella I; Soldà G; Afrasiabi A; Menegatti M; Shamsi T; Peyvandi F; Duga S
Thromb Haemost; 2015 Mar; 113(3):567-76. PubMed ID: 25427968
[TBL] [Abstract][Full Text] [Related]
4. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen as a Pleiotropic Protein Causing Human Diseases: The Mutational Burden of Aα, Bβ, and γ Chains.
Paraboschi EM; Duga S; Asselta R
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29240685
[TBL] [Abstract][Full Text] [Related]
6. Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects.
Monaldini L; Asselta R; Duga S; Peyvandi F; Karimi M; Malcovati M; Tenchini ML
Thromb Haemost; 2007 Apr; 97(4):546-51. PubMed ID: 17393016
[TBL] [Abstract][Full Text] [Related]
7. Congenital hypofibrinogenemia associated with novel homozygous fibrinogen Aα and heterozygous Bβ chain mutations.
Castaman G; Rimoldi V; Giacomelli SH; Duga S
Thromb Res; 2015 Jul; 136(1):144-7. PubMed ID: 25981141
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.
Asselta R; Spena S; Duga S; Peyvandi F; Malcovati M; Mannucci PM; Tenchini ML
Haematologica; 2002 Aug; 87(8):855-9. PubMed ID: 12161363
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations.
Neerman-Arbez M; de Moerloose P
Hum Mutat; 2007 Jun; 28(6):540-53. PubMed ID: 17295221
[TBL] [Abstract][Full Text] [Related]
10. Rare inherited disorders of fibrinogen.
Acharya SS; Dimichele DM
Haemophilia; 2008 Nov; 14(6):1151-8. PubMed ID: 19141154
[TBL] [Abstract][Full Text] [Related]
11. Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia.
Vu D; Di Sanza C; Caille D; de Moerloose P; Scheib H; Meda P; Neerman-Arbez M
Hum Mol Genet; 2005 Nov; 14(21):3271-80. PubMed ID: 16195396
[TBL] [Abstract][Full Text] [Related]
12. Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations.
Tavasoli B; Safa M; Dorgalaleh A; Ghasemi JB; Rezaei Makhouri F; Rezvani MR; Ahmadi A; Tabibian S; Jazebi M; Baghaipour MR; Zaker F
Int J Lab Hematol; 2020 Oct; 42(5):619-627. PubMed ID: 32639687
[TBL] [Abstract][Full Text] [Related]
13. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative.
Yoda M; Kaido T; Taira C; Higuchi Y; Arai S; Okumura N
Thromb Res; 2020 Dec; 196():152-158. PubMed ID: 32871307
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of quantitative fibrinogen disorders.
Asselta R; Spena S; Duga S; Tenchini ML
Cardiovasc Hematol Agents Med Chem; 2007 Apr; 5(2):163-73. PubMed ID: 17430139
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of quantitative fibrinogen disorders.
Asselta R; Duga S; Tenchini ML
J Thromb Haemost; 2006 Oct; 4(10):2115-29. PubMed ID: 16999847
[TBL] [Abstract][Full Text] [Related]
16. Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion.
Vu D; de Moerloose P; Batorova A; Lazur J; Palumbo L; Neerman-Arbez M
J Med Genet; 2005 Sep; 42(9):e57. PubMed ID: 16141000
[TBL] [Abstract][Full Text] [Related]
17. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
[TBL] [Abstract][Full Text] [Related]
18. Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module.
Asselta R; Robusto M; Braidotti P; Peyvandi F; Nastasio S; D'Antiga L; Perisic VN; Maggiore G; Caccia S; Duga S
J Thromb Haemost; 2015 Aug; 13(8):1459-67. PubMed ID: 26039544
[TBL] [Abstract][Full Text] [Related]
19. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion.
Vu D; Bolton-Maggs PH; Parr JR; Morris MA; de Moerloose P; Neerman-Arbez M
Blood; 2003 Dec; 102(13):4413-5. PubMed ID: 12893758
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of the first missense mutation in the fibrinogen Aalpha-chain gene identified in a compound heterozygous afibrinogenemic patient.
Platé M; Asselta R; Peyvandi F; Tenchini ML; Duga S
Biochim Biophys Acta; 2007 Jul; 1772(7):781-7. PubMed ID: 17531448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
